Polyacrylic acid-coated iron oxide nanoparticles could be a useful tool for tracking inflammatory monocytes

Manuela Giraldo-Villegas1, Jeaneth Urquijo2, Oscar L Arnache-Olmos2

  • 1Grupo de Inmunología Celular e Inmunogenética, Sede de Investigación Universitaria (SIU), Universidad de Antioquia (UDEA), Calle 70 No. 52-21, Medellín, Colombia.

Future Science OA
|December 13, 2019
PubMed
Abstract

Insights

Poly(acrylic acid)-coated iron oxide nanoparticles (PAC-IONs) are safe and biocompatible, showing no adverse effects on mononuclear phagocyte differentiation into macrophages. Their selective uptake by monocytes suggests potential for in vivo tracking applications.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Immunology

Background:

  • Mononuclear phagocytes are crucial immune cells.
  • Iron oxide nanoparticles (IONs) offer potential for biomedical applications.
  • Poly(acrylic acid) coating enhances nanoparticle biocompatibility.

Purpose of the Study:

  • To investigate the effects of poly(acrylic acid)-coated iron oxide nanoparticles (PAC-IONs) on mononuclear phagocyte differentiation.
  • To assess the impact of magnetic field exposure on PAC-IONs and cell differentiation.
  • To evaluate the safety and biocompatibility of PAC-IONs.

Main Methods:

  • Flow cytometry was used to assess cell death markers (DIOC6, PI, PARP fragmentation, H2AX phosphorylation, TUNEL assay).
  • Cytokine profiles were analyzed using a Cytokine bead array.
  • Intracellular iron content was quantified via atomic absorption spectrometry.

Main Results:

  • PAC-IONs did not induce apoptosis or compromise cell membrane integrity.
  • Mitochondrial membrane potential and cell morphology remained unaffected.
  • PAC-IONs did not alter cytokine accumulation or the macrophage differentiation's effect on T cell proliferation.

Conclusions:

  • PAC-IONs demonstrate safety and biocompatibility.
  • PAC-IONs exhibit selectivity for mononuclear phagocytes, particularly non-classical monocytes.
  • Further research is warranted for PAC-IONs as contrast agents for in vivo tracking of immune cells.

Related Concept Videos